1998
DOI: 10.1016/s0165-1781(98)00101-2
|View full text |Cite
|
Sign up to set email alerts
|

Positive and negative schizotypal symptoms relate to different aspects of crossover reaction time task performance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
10
0

Year Published

2004
2004
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(11 citation statements)
references
References 34 publications
1
10
0
Order By: Relevance
“…The link between positive symptoms of psychosis and paranormal/positive schizotypal traits is further evidenced by studies showing that psychometrically assessed positive schizotypal individuals, even if completely healthy, perform similarly to patients with schizophrenia in sensory (Mohr, Rohrenbach, Laska, & Brugger, 2001;Kwapil, Chapman, Chapman, & Miller, 1996), cognitive (Tallent & Gooding, 1999;Duchene, Graves, & Brugger, 1998), and attentional tasks Sarkin, Dionisio, Hillix, & Granholm, 1998;Brugger & Graves, 1997a). Of particular relevance to the present study, these similarities are also evident for lateralized neuropsychological functions (Brugger, 2007;Barnett & Corballis, 2002;Pizzagalli et al, 2000;Chapman & Chapman, 1987a).…”
Section: Introductionsupporting
confidence: 67%
“…The link between positive symptoms of psychosis and paranormal/positive schizotypal traits is further evidenced by studies showing that psychometrically assessed positive schizotypal individuals, even if completely healthy, perform similarly to patients with schizophrenia in sensory (Mohr, Rohrenbach, Laska, & Brugger, 2001;Kwapil, Chapman, Chapman, & Miller, 1996), cognitive (Tallent & Gooding, 1999;Duchene, Graves, & Brugger, 1998), and attentional tasks Sarkin, Dionisio, Hillix, & Granholm, 1998;Brugger & Graves, 1997a). Of particular relevance to the present study, these similarities are also evident for lateralized neuropsychological functions (Brugger, 2007;Barnett & Corballis, 2002;Pizzagalli et al, 2000;Chapman & Chapman, 1987a).…”
Section: Introductionsupporting
confidence: 67%
“…Originally, we expected that performance would deteriorate under a DA agonist given that (1) DA agonists can worsen psychotic symptoms in patients with schizophrenia (Davidson et al, 1987;Abi-Dargham et al, 1998) and trigger psychotic symptoms in healthy participants (Janowsky and Risch, 1979;Sekine et al, 2001); (2) schizotypy and schizophrenia share cognitive (Gooding et al, 1999;Park, 1999), attentional (Sarkin et al, 1998;Mohr et al, 2003a), behavioral (Barnett and Corballis, 2002;Mohr et al, 2003b), and physiological (Klein et al, 1999;Pizzagalli et al, 2000) similarities; and (3) DA agonists increase stereotyped responding in animals (Randrup and Munkvad, 1974;Staton and Solomon, 1984;Kelley et al, 1988) and healthy populations (Connell, 1958;Ridley et al, 1988). Findings from animal (Arnsten, 1997;Williams and Goldman-Rakic, 1995) and human (Mehta et al, 2000) studies propose that dopaminergic actions follow an inverted Ushape function, with an improvement of cognitive performance from low to medium, but deterioration from medium to high doses.…”
Section: Discussionmentioning
confidence: 99%
“…Second, this line of research became well accepted to study brain functions related to schizophrenia free from confounding correlates of severe clinical symptoms such as medication and institutionalization (eg Gooding et al, 1999;Avons et al, 2003). In fact, preselected and unselected schizotypal individuals, thought to be 'psychosis-prone' (Chapman et al, 1994;Kwapil et al, 1997), perform similar to patients with schizophrenia for cognitive (Gooding et al, 1999;Park, 1999), attentional (Sarkin et al, 1998;Mohr et al, 2003a), behavioral (Barnett and Corballis, 2002;Mohr et al, 2003b) and physiological (Klein et al, 1999;Pizzagalli et al, 2000) measures. Finally, alterations of dopaminergic responsivity may accompany the schizophrenia spectrum disorders in a continuous manner; the DA metabolite homovanillin acid (HVA) correlated with severity of positive symptoms in schizophrenia (Pickar et al, 1984;Davidson and Davis, 1988) and the extent of schizotypal personality disorder (Siever et al, 1991(Siever et al, , 1993.…”
Section: Introductionmentioning
confidence: 99%
“…Schizotypy is typically assessed using self-report questionnaires (Chapman, Chapman, Kwapil, Eckblad, & Zinser, 1994;Mason, Claridge, & Jackson, 1995;Raine, 1991) and high scores might indicate enhanced proneness to psychosis (Chapman et al, 1994;Gooding, Tallent, & Matts, 2005). The notion that schizotypy and overt clinical psychosis are linked is also supported by observations that high-scoring, pre-selected schizotypal individuals from the general population demonstrate cognitive-attentional (Buchy, Woodward, & Liotti, 2007;Gooding, Kwapil, & Tallent, 1999;Sarkin, Dionisio, Hillix, & Granholm, 1998), sensorymotor-behavioral (Lenzenweger & Gold, 2000), physiological (Klein, Berg, Rockstroh, & Andresen, 1999;Pizzagalli et al, 2000) and neurochemical (Laruelle & Abi-Dargham, 1999;Murray, Lappin, & Di Forti, 2008) peculiarities comparable to those described in patients with schizophrenia.…”
Section: Introductionmentioning
confidence: 99%